Screener

486 companies · every ratio sourced from the company's own NSE filing. Update the cache with python manage.py refresh_market_data. Looking to browse the whole universe instead of filtering it? See Browse all companies.

Sector

ROE >

Debt/Equity <

Preset screen

Custom formula Metric names & syntax

Clear

ℹ A custom screen is a filter you defined. StockProof computes the metrics and reports which companies satisfy the condition you wrote — it does not assess, endorse or rank the strategy behind it, and a company appearing in these results is not a recommendation to buy or sell. Companies missing an input your formula needs are listed separately as “couldn't be judged”, never counted as non-matches.

Write a condition using the metric names below, the comparisons > < >= <= == !=, the words and / or / not, parentheses, and arithmetic + - * /. Names and keywords are case-insensitive. Up to 500 characters.

Examples: roe > 15 and debt_to_equity < 1 and pe < 20 · P/E < 20 or (dividend_yield > 3 and D/E < 0.5) · rsi < 30 and delivery_percent > 50 · not (market_cap < 5000)

Percentages are typed as percentages — roe > 15 means 15%, matching the “ROE >” filter above and the table's own “15.00%”. Market cap is in crore, so market_cap > 50000 means ₹50,000 Cr. Comparisons can't be chained: write pe > 1 and pe < 20, not 1 < pe < 20.

Valuation & fundamentals (latest filing + price snapshot)

Type this	Metric	Unit	What it is
pe · P/E · pe_ratio · price_to_earnings	P/E	ratio	Price / Diluted EPS from the latest filing.
roe · return_on_equity	ROE	percent	Net Income / Shareholder Equity, in percent.
debt_to_equity · D/E · de · debt_equity	Debt/Equity	ratio	Total debt / shareholder equity.
current_ratio	Current Ratio	ratio	Current assets / current liabilities.
roce · return_on_capital_employed	ROCE	percent	Return on capital employed, in percent.
dividend_yield · div_yield	Dividend Yield	percent	Dividend per share / price, in percent.
market_cap · mcap · marketcap	Market Cap	crore	Price x diluted shares outstanding, in CRORE (50000 means Rs 50,000 Cr).
pb · P/B · price_to_book	P/B	ratio	Price / book value per share.
ev_ebitda · EV/EBITDA	EV/EBITDA	ratio	Enterprise value / EBITDA.
earnings_yield	Earnings Yield	percent	EBIT / enterprise value, in percent.
price · close	Price	rupees	Latest stored price snapshot, in rupees.

Price & volume technicals (stored daily history)

Type this	Metric	Unit	What it is
rsi · rsi_14	RSI (14-day)	0-100	Wilder's 14-day Relative Strength Index.
week52_high · high_52w	52-Week High	rupees	Highest intraday high in the trailing 52 weeks.
week52_low · low_52w	52-Week Low	rupees	Lowest intraday low in the trailing 52 weeks.
pct_below_52w_high · off_52w_high	% Below 52W High	percent	How far the latest close sits BELOW the 52-week high, in percent (0 = at the high).
pct_above_52w_low · off_52w_low	% Above 52W Low	percent	How far the latest close sits ABOVE the 52-week low, in percent (0 = at the low).
delivery_percent · delivery_pct	Delivery %	percent	Trailing 20-day average NSE delivery percentage (already in percent points).
macd · macd_line	MACD Line	rupees	12/26-day EMA difference (Appel).
macd_signal	MACD Signal	rupees	9-day EMA of the MACD line.
macd_histogram · macd_hist	MACD Histogram	rupees	MACD line minus signal line.
bb_upper	Bollinger Upper	rupees	20-day SMA + 2 population std dev.
bb_middle	Bollinger Middle	rupees	20-day simple moving average.
bb_lower	Bollinger Lower	rupees	20-day SMA - 2 population std dev.
bb_percent_b · percent_b	Bollinger %B	ratio	Position of the close within the bands: 0 at the lower band, 1 at the upper.
bb_bandwidth	Bollinger Bandwidth	ratio	(upper - lower) / middle -- Bollinger's relative volatility measure.
stoch_k · stochastic_k	Stochastic %K	0-100	Lane's 14-day Fast Stochastic %K.
stoch_d · stochastic_d	Stochastic %D	0-100	3-day simple moving average of %K.
mfi · mfi_14	MFI (14-day)	0-100	14-day Money Flow Index (volume-weighted RSI).
atr	ATR (14-day)	rupees	Wilder's 14-day Average True Range, in rupees.
atr_percent · atr_pct	ATR % of Price	percent	ATR as a percentage of the latest close.
adx	ADX (14-day)	0-100	Wilder's Average Directional Index.
plus_di	+DI	0-100	Wilder's positive directional indicator.
minus_di	-DI	0-100	Wilder's negative directional indicator.
dma_50 · sma_50	50-DMA	rupees	50-day simple moving average of the close.
dma_200 · sma_200	200-DMA	rupees	200-day simple moving average of the close.
volume	Volume (latest day)	shares	Traded quantity on the latest stored trading day.

Growth (stored multi-year annual history)

Type this	Metric	Unit	What it is
revenue_cagr_3y	3y Revenue CAGR	percent	Compound annual revenue growth over ~3 stored years, in percent.
revenue_cagr_5y	5y Revenue CAGR	percent	Compound annual revenue growth over ~5 stored years, in percent.
profit_cagr_3y	3y Net Profit CAGR	percent	Compound annual net-profit growth over ~3 stored years, in percent.
profit_cagr_5y	5y Net Profit CAGR	percent	Compound annual net-profit growth over ~5 stored years, in percent.

Piotroski F-Score — 9-criteria profitability, leverage, and efficiency composite.

13 results Extract this table (respects filters): CSV · XLSX

Ticker

Company

Sector

Trend

F-Score

Piotroski F-Score

Criteria

Watchlist

FORTIS.NS

Fortis Healthcare Ltd.

Healthcare

8/9

▲ Strong (Piotroski's 8–9 band)

8 of 9 criteria met

9 criteria

✓ Met Positive net income	Net Profit 2026-03-31: ₹10,417,800,000	ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✓ Met Positive operating cash flow	CFO 2026-03-31: ₹16,018,000,000	CashFlowsFromUsedInOperatingActivities (2026-03-31)
✓ Met Return on assets improved YoY	ROA 2025-03-31 → 2026-03-31: 5.65% → 6.52%	Net Profit ÷ Total Assets, 2025-03-31 & 2026-03-31
✓ Met Operating cash flow exceeds net income	CFO ₹16,018,000,000 vs Net Profit ₹10,417,800,000 (2026-03-31)	CashFlowsFromUsedInOperatingActivities vs ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✓ Met Leverage (Debt/Assets) decreased YoY	2025-03-31 → 2026-03-31: 18.08% → 17.99%	Total Debt ÷ Total Assets, 2025-03-31 & 2026-03-31
✗ Not met Current ratio improved YoY	2025-03-31 → 2026-03-31: 1.35 → 0.86	Total Current Assets ÷ Total Current Liabilities, 2025-03-31 & 2026-03-31
✓ Met No new shares issued	Equity Share Capital 2025-03-31 → 2026-03-31: ₹7,549,600,000 → ₹7,549,600,000	EquityShareCapital, 2025-03-31 & 2026-03-31
✓ Met Operating margin (EBIT/Revenue) improved YoY	2025-03-31 → 2026-03-31: 16.31% → 18.47%	(ProfitBeforeExceptionalItemsAndTax + FinanceCosts) ÷ Revenue from Operations, 2025-03-31 & 2026-03-31
✓ Met Asset turnover improved YoY	2025-03-31 → 2026-03-31: 0.57 → 0.57	Revenue from Operations ÷ Total Assets, 2025-03-31 & 2026-03-31

SONATSOFTW.NS

Sonata Software Ltd.

Information Technology

7/9

7 of 9 criteria met

9 criteria

✓ Met Positive net income	Net Profit 2026-03-31: ₹4,643,900,000	ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✓ Met Positive operating cash flow	CFO 2026-03-31: ₹5,380,200,000	CashFlowsFromUsedInOperatingActivities (2026-03-31)
✓ Met Return on assets improved YoY	ROA 2025-03-31 → 2026-03-31: 8.93% → 9.12%	Net Profit ÷ Total Assets, 2025-03-31 & 2026-03-31
✓ Met Operating cash flow exceeds net income	CFO ₹5,380,200,000 vs Net Profit ₹4,643,900,000 (2026-03-31)	CashFlowsFromUsedInOperatingActivities vs ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✗ Not met Leverage (Debt/Assets) decreased YoY	2025-03-31 → 2026-03-31: 9.29% → 11.16%	Total Debt ÷ Total Assets, 2025-03-31 & 2026-03-31
✓ Met Current ratio improved YoY	2025-03-31 → 2026-03-31: 1.04 → 1.05	Total Current Assets ÷ Total Current Liabilities, 2025-03-31 & 2026-03-31
✓ Met No new shares issued	Equity Share Capital 2025-03-31 → 2026-03-31: ₹277,600,000 → ₹276,800,000	EquityShareCapital, 2025-03-31 & 2026-03-31
✓ Met Operating margin (EBIT/Revenue) improved YoY	2025-03-31 → 2026-03-31: 6.29% → 6.93%	(ProfitBeforeExceptionalItemsAndTax + FinanceCosts) ÷ Revenue from Operations, 2025-03-31 & 2026-03-31
✗ Not met Asset turnover improved YoY	2025-03-31 → 2026-03-31: 2.14 → 2.10	Revenue from Operations ÷ Total Assets, 2025-03-31 & 2026-03-31

INTELLECT.NS

Intellect Design Arena Ltd.

Information Technology

6/9

6 of 9 criteria met

9 criteria

✓ Met Positive net income	Net Profit 2026-03-31: ₹3,454,330,000	ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✓ Met Positive operating cash flow	CFO 2026-03-31: ₹5,104,950,000	CashFlowsFromUsedInOperatingActivities (2026-03-31)
✓ Met Return on assets improved YoY	ROA 2025-03-31 → 2026-03-31: 0.00% → 7.54%	Net Profit ÷ Total Assets, 2025-03-31 & 2026-03-31
✓ Met Operating cash flow exceeds net income	CFO ₹5,104,950,000 vs Net Profit ₹3,454,330,000 (2026-03-31)	CashFlowsFromUsedInOperatingActivities vs ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✓ Met Leverage (Debt/Assets) decreased YoY	2025-03-31 → 2026-03-31: 0.80% → 0.00%	Total Debt ÷ Total Assets, 2025-03-31 & 2026-03-31
✗ Not met Current ratio improved YoY	2025-03-31 → 2026-03-31: 2.14 → 2.11	Total Current Assets ÷ Total Current Liabilities, 2025-03-31 & 2026-03-31
✗ Not met No new shares issued	Equity Share Capital 2025-03-31 → 2026-03-31: ₹694,260,000 → ₹698,390,000	EquityShareCapital, 2025-03-31 & 2026-03-31
✗ Not met Operating margin (EBIT/Revenue) improved YoY	2025-03-31 → 2026-03-31: 18.05% → 16.26%	(ProfitBeforeExceptionalItemsAndTax + FinanceCosts) ÷ Revenue from Operations, 2025-03-31 & 2026-03-31
✓ Met Asset turnover improved YoY	2025-03-31 → 2026-03-31: 0.64 → 0.66	Revenue from Operations ÷ Total Assets, 2025-03-31 & 2026-03-31

ASTERDM.NS

Aster DM Quality Care Ltd.

Healthcare

5/9

5 of 9 criteria met

9 criteria

✓ Met Positive net income	Net Profit 2026-03-31: ₹3,881,400,000	ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✓ Met Positive operating cash flow	CFO 2026-03-31: ₹6,559,200,000	CashFlowsFromUsedInOperatingActivities (2026-03-31)
✗ Not met Return on assets improved YoY	ROA 2025-03-31 → 2026-03-31: 81.40% → 4.78%	Net Profit ÷ Total Assets, 2025-03-31 & 2026-03-31
✓ Met Operating cash flow exceeds net income	CFO ₹6,559,200,000 vs Net Profit ₹3,881,400,000 (2026-03-31)	CashFlowsFromUsedInOperatingActivities vs ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✓ Met Leverage (Debt/Assets) decreased YoY	2025-03-31 → 2026-03-31: 9.72% → 8.64%	Total Debt ÷ Total Assets, 2025-03-31 & 2026-03-31
✗ Not met Current ratio improved YoY	2025-03-31 → 2026-03-31: 2.16 → 1.99	Total Current Assets ÷ Total Current Liabilities, 2025-03-31 & 2026-03-31
✗ Not met No new shares issued	Equity Share Capital 2025-03-31 → 2026-03-31: ₹4,995,200,000 → ₹5,181,300,000	EquityShareCapital, 2025-03-31 & 2026-03-31
✓ Met Operating margin (EBIT/Revenue) improved YoY	2025-03-31 → 2026-03-31: 16.04% → 16.42%	(ProfitBeforeExceptionalItemsAndTax + FinanceCosts) ÷ Revenue from Operations, 2025-03-31 & 2026-03-31
✗ Not met Asset turnover improved YoY	2025-03-31 → 2026-03-31: 0.63 → 0.57	Revenue from Operations ÷ Total Assets, 2025-03-31 & 2026-03-31

WAAREEENER.NS

Waaree Energies Ltd.

Capital Goods

5/9

5 of 9 criteria met

9 criteria

✓ Met Positive net income	Net Profit 2026-03-31: ₹37,113,000,000	ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✓ Met Positive operating cash flow	CFO 2026-03-31: ₹16,269,500,000	CashFlowsFromUsedInOperatingActivities (2026-03-31)
✓ Met Return on assets improved YoY	ROA 2025-03-31 → 2026-03-31: 9.46% → 12.32%	Net Profit ÷ Total Assets, 2025-03-31 & 2026-03-31
✗ Not met Operating cash flow exceeds net income	CFO ₹16,269,500,000 vs Net Profit ₹37,113,000,000 (2026-03-31)	CashFlowsFromUsedInOperatingActivities vs ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✗ Not met Leverage (Debt/Assets) decreased YoY	2025-03-31 → 2026-03-31: 4.76% → 8.27%	Total Debt ÷ Total Assets, 2025-03-31 & 2026-03-31
✗ Not met Current ratio improved YoY	2025-03-31 → 2026-03-31: 1.50 → 1.39	Total Current Assets ÷ Total Current Liabilities, 2025-03-31 & 2026-03-31
✗ Not met No new shares issued	Equity Share Capital 2025-03-31 → 2026-03-31: ₹2,872,800,000 → ₹2,876,500,000	EquityShareCapital, 2025-03-31 & 2026-03-31
✓ Met Operating margin (EBIT/Revenue) improved YoY	2025-03-31 → 2026-03-31: 18.84% → 21.20%	(ProfitBeforeExceptionalItemsAndTax + FinanceCosts) ÷ Revenue from Operations, 2025-03-31 & 2026-03-31
✓ Met Asset turnover improved YoY	2025-03-31 → 2026-03-31: 0.73 → 0.88	Revenue from Operations ÷ Total Assets, 2025-03-31 & 2026-03-31

HEXT.NS

Hexaware Technologies Ltd.

Information Technology

4/9

4 of 9 criteria met

9 criteria

✓ Met Positive net income	Net Profit 2025-12-31: ₹13,692,000,000	ProfitOrLossAttributableToOwnersOfParent (2025-12-31)
✓ Met Positive operating cash flow	CFO 2025-12-31: ₹17,391,000,000	CashFlowsFromUsedInOperatingActivities (2025-12-31)
✗ Not met Return on assets improved YoY	ROA 2024-12-31 → 2025-12-31: 13.08% → 12.56%	Net Profit ÷ Total Assets, 2024-12-31 & 2025-12-31
✓ Met Operating cash flow exceeds net income	CFO ₹17,391,000,000 vs Net Profit ₹13,692,000,000 (2025-12-31)	CashFlowsFromUsedInOperatingActivities vs ProfitOrLossAttributableToOwnersOfParent (2025-12-31)
✗ Not met Leverage (Debt/Assets) decreased YoY	2024-12-31 → 2025-12-31: 0.00% → 0.00%	Total Debt ÷ Total Assets, 2024-12-31 & 2025-12-31
✗ Not met Current ratio improved YoY	2024-12-31 → 2025-12-31: 1.58 → 1.44	Total Current Assets ÷ Total Current Liabilities, 2024-12-31 & 2025-12-31
✗ Not met No new shares issued	Equity Share Capital 2024-12-31 → 2025-12-31: ₹608,000,000 → ₹609,000,000	EquityShareCapital, 2024-12-31 & 2025-12-31
✓ Met Operating margin (EBIT/Revenue) improved YoY	2024-12-31 → 2025-12-31: 13.58% → 14.43%	(ProfitBeforeExceptionalItemsAndTax + FinanceCosts) ÷ Revenue from Operations, 2024-12-31 & 2025-12-31
✗ Not met Asset turnover improved YoY	2024-12-31 → 2025-12-31: 1.33 → 1.23	Revenue from Operations ÷ Total Assets, 2024-12-31 & 2025-12-31

OFSS.NS

Oracle Financial Services Software Ltd.

Information Technology

4/9

4 of 9 criteria met

9 criteria

✓ Met Positive net income	Net Profit 2026-03-31: ₹26,393,000,000	ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✓ Met Positive operating cash flow	CFO 2026-03-31: ₹26,383,000,000	CashFlowsFromUsedInOperatingActivities (2026-03-31)
✓ Met Return on assets improved YoY	ROA 2025-03-31 → 2026-03-31: 23.48% → 26.57%	Net Profit ÷ Total Assets, 2025-03-31 & 2026-03-31
✗ Not met Operating cash flow exceeds net income	CFO ₹26,383,000,000 vs Net Profit ₹26,393,000,000 (2026-03-31)	CashFlowsFromUsedInOperatingActivities vs ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✗ Not met Leverage (Debt/Assets) decreased YoY	2025-03-31 → 2026-03-31: 0.00% → 0.00%	Total Debt ÷ Total Assets, 2025-03-31 & 2026-03-31
✗ Not met Current ratio improved YoY	2025-03-31 → 2026-03-31: 6.90 → 5.44	Total Current Assets ÷ Total Current Liabilities, 2025-03-31 & 2026-03-31
✗ Not met No new shares issued	Equity Share Capital 2025-03-31 → 2026-03-31: ₹434,000,000 → ₹435,000,000	EquityShareCapital, 2025-03-31 & 2026-03-31
✗ Not met Operating margin (EBIT/Revenue) improved YoY	2025-03-31 → 2026-03-31: 48.36% → 48.00%	(ProfitBeforeExceptionalItemsAndTax + FinanceCosts) ÷ Revenue from Operations, 2025-03-31 & 2026-03-31
✓ Met Asset turnover improved YoY	2025-03-31 → 2026-03-31: 0.68 → 0.77	Revenue from Operations ÷ Total Assets, 2025-03-31 & 2026-03-31

SAREGAMA.NS

Saregama India Ltd

Media Entertainment & Publication

4/9

4 of 9 criteria met

9 criteria

✓ Met Positive net income	Net Profit 2026-03-31: ₹2,070,700,000	ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✓ Met Positive operating cash flow	CFO 2026-03-31: ₹1,000,200,000	CashFlowsFromUsedInOperatingActivities (2026-03-31)
✗ Not met Return on assets improved YoY	ROA 2025-03-31 → 2026-03-31: 9.75% → 8.92%	Net Profit ÷ Total Assets, 2025-03-31 & 2026-03-31
✗ Not met Operating cash flow exceeds net income	CFO ₹1,000,200,000 vs Net Profit ₹2,070,700,000 (2026-03-31)	CashFlowsFromUsedInOperatingActivities vs ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✗ Not met Leverage (Debt/Assets) decreased YoY	2025-03-31 → 2026-03-31: 0.00% → 3.03%	Total Debt ÷ Total Assets, 2025-03-31 & 2026-03-31
✗ Not met Current ratio improved YoY	2025-03-31 → 2026-03-31: 2.87 → 1.75	Total Current Assets ÷ Total Current Liabilities, 2025-03-31 & 2026-03-31
✓ Met No new shares issued	Equity Share Capital 2025-03-31 → 2026-03-31: ₹192,800,000 → ₹192,800,000	EquityShareCapital, 2025-03-31 & 2026-03-31
✓ Met Operating margin (EBIT/Revenue) improved YoY	2025-03-31 → 2026-03-31: 23.63% → 30.21%	(ProfitBeforeExceptionalItemsAndTax + FinanceCosts) ÷ Revenue from Operations, 2025-03-31 & 2026-03-31
✗ Not met Asset turnover improved YoY	2025-03-31 → 2026-03-31: 0.56 → 0.42	Revenue from Operations ÷ Total Assets, 2025-03-31 & 2026-03-31

ARE&M.NS

Amara Raja Energy & Mobility Ltd.

Automobile and Auto Components

3/9

3 of 9 criteria met

9 criteria

✗ Not met Positive net income	Net Profit 2026-03-31: ₹0	ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✓ Met Positive operating cash flow	CFO 2026-03-31: ₹11,182,900,000	CashFlowsFromUsedInOperatingActivities (2026-03-31)
✗ Not met Return on assets improved YoY	ROA 2025-03-31 → 2026-03-31: 0.00% → 0.00%	Net Profit ÷ Total Assets, 2025-03-31 & 2026-03-31
✓ Met Operating cash flow exceeds net income	CFO ₹11,182,900,000 vs Net Profit ₹0 (2026-03-31)	CashFlowsFromUsedInOperatingActivities vs ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✗ Not met Leverage (Debt/Assets) decreased YoY	2025-03-31 → 2026-03-31: 1.42% → 2.41%	Total Debt ÷ Total Assets, 2025-03-31 & 2026-03-31
✗ Not met Current ratio improved YoY	2025-03-31 → 2026-03-31: 1.84 → 1.64	Total Current Assets ÷ Total Current Liabilities, 2025-03-31 & 2026-03-31
✓ Met No new shares issued	Equity Share Capital 2025-03-31 → 2026-03-31: ₹183,000,000 → ₹183,000,000	EquityShareCapital, 2025-03-31 & 2026-03-31
✗ Not met Operating margin (EBIT/Revenue) improved YoY	2025-03-31 → 2026-03-31: 9.39% → 7.21%	(ProfitBeforeExceptionalItemsAndTax + FinanceCosts) ÷ Revenue from Operations, 2025-03-31 & 2026-03-31
✗ Not met Asset turnover improved YoY	2025-03-31 → 2026-03-31: 1.26 → 1.21	Revenue from Operations ÷ Total Assets, 2025-03-31 & 2026-03-31

BLUEJET.NS

Blue Jet Healthcare Ltd.

Healthcare

3/9

3 of 6 computable criteria met (6 of 9 total computable)

9 criteria

N/A — not computable Positive net income	Net profit not disclosed for this year.	—
✓ Met Positive operating cash flow	CFO 2026-03-31: ₹3,341,460,000	CashFlowsFromUsedInOperatingActivities (2026-03-31)
N/A — not computable Return on assets improved YoY	Net profit or total assets missing in one of the two years.	—
N/A — not computable Operating cash flow exceeds net income	CFO or net profit not disclosed for this year.	—
✗ Not met Leverage (Debt/Assets) decreased YoY	2025-03-31 → 2026-03-31: 0.00% → 0.00%	Total Debt ÷ Total Assets, 2025-03-31 & 2026-03-31
✓ Met Current ratio improved YoY	2025-03-31 → 2026-03-31: 3.93 → 4.21	Total Current Assets ÷ Total Current Liabilities, 2025-03-31 & 2026-03-31
✓ Met No new shares issued	Equity Share Capital 2025-03-31 → 2026-03-31: ₹346,930,000 → ₹346,930,000	EquityShareCapital, 2025-03-31 & 2026-03-31
✗ Not met Operating margin (EBIT/Revenue) improved YoY	2025-03-31 → 2026-03-31: 39.44% → 35.76%	(ProfitBeforeExceptionalItemsAndTax + FinanceCosts) ÷ Revenue from Operations, 2025-03-31 & 2026-03-31
✗ Not met Asset turnover improved YoY	2025-03-31 → 2026-03-31: 0.73 → 0.58	Revenue from Operations ÷ Total Assets, 2025-03-31 & 2026-03-31

MAXHEALTH.NS

Max Healthcare Institute Ltd.

Healthcare

3/9

3 of 6 computable criteria met (6 of 9 total computable)

9 criteria

N/A — not computable Positive net income	Net profit not disclosed for this year.	—
✓ Met Positive operating cash flow	CFO 2026-03-31: ₹16,333,200,000	CashFlowsFromUsedInOperatingActivities (2026-03-31)
N/A — not computable Return on assets improved YoY	Net profit or total assets missing in one of the two years.	—
N/A — not computable Operating cash flow exceeds net income	CFO or net profit not disclosed for this year.	—
✗ Not met Leverage (Debt/Assets) decreased YoY	2025-03-31 → 2026-03-31: 19.79% → 20.19%	Total Debt ÷ Total Assets, 2025-03-31 & 2026-03-31
✓ Met Current ratio improved YoY	2025-03-31 → 2026-03-31: 0.88 → 0.89	Total Current Assets ÷ Total Current Liabilities, 2025-03-31 & 2026-03-31
✗ Not met No new shares issued	Equity Share Capital 2025-03-31 → 2026-03-31: ₹9,721,400,000 → ₹9,731,300,000	EquityShareCapital, 2025-03-31 & 2026-03-31
✗ Not met Operating margin (EBIT/Revenue) improved YoY	2025-03-31 → 2026-03-31: 23.41% → 23.39%	(ProfitBeforeExceptionalItemsAndTax + FinanceCosts) ÷ Revenue from Operations, 2025-03-31 & 2026-03-31
✓ Met Asset turnover improved YoY	2025-03-31 → 2026-03-31: 0.46 → 0.49	Revenue from Operations ÷ Total Assets, 2025-03-31 & 2026-03-31

NEWGEN.NS

Newgen Software Technologies Ltd.

Information Technology

3/9

3 of 9 criteria met

9 criteria

✓ Met Positive net income	Net Profit 2026-03-31: ₹3,005,764,000	ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✓ Met Positive operating cash flow	CFO 2026-03-31: ₹2,318,593,000	CashFlowsFromUsedInOperatingActivities (2026-03-31)
✗ Not met Return on assets improved YoY	ROA 2025-03-31 → 2026-03-31: 15.41% → 12.31%	Net Profit ÷ Total Assets, 2025-03-31 & 2026-03-31
✗ Not met Operating cash flow exceeds net income	CFO ₹2,318,593,000 vs Net Profit ₹3,005,764,000 (2026-03-31)	CashFlowsFromUsedInOperatingActivities vs ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✗ Not met Leverage (Debt/Assets) decreased YoY	2025-03-31 → 2026-03-31: 0.00% → 0.00%	Total Debt ÷ Total Assets, 2025-03-31 & 2026-03-31
✗ Not met Current ratio improved YoY	2025-03-31 → 2026-03-31: 3.86 → 3.70	Total Current Assets ÷ Total Current Liabilities, 2025-03-31 & 2026-03-31
✗ Not met No new shares issued	Equity Share Capital 2025-03-31 → 2026-03-31: ₹1,402,130,000 → ₹1,411,595,000	EquityShareCapital, 2025-03-31 & 2026-03-31
✓ Met Operating margin (EBIT/Revenue) improved YoY	2025-03-31 → 2026-03-31: 27.36% → 27.70%	(ProfitBeforeExceptionalItemsAndTax + FinanceCosts) ÷ Revenue from Operations, 2025-03-31 & 2026-03-31
✗ Not met Asset turnover improved YoY	2025-03-31 → 2026-03-31: 0.73 → 0.64	Revenue from Operations ÷ Total Assets, 2025-03-31 & 2026-03-31

RAINBOW.NS

Rainbow Childrens Medicare Ltd.

Healthcare

3/9

3 of 9 criteria met

9 criteria

✓ Met Positive net income	Net Profit 2026-03-31: ₹2,783,230,000	ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✓ Met Positive operating cash flow	CFO 2026-03-31: ₹4,196,550,000	CashFlowsFromUsedInOperatingActivities (2026-03-31)
✗ Not met Return on assets improved YoY	ROA 2025-03-31 → 2026-03-31: 10.24% → 10.03%	Net Profit ÷ Total Assets, 2025-03-31 & 2026-03-31
✓ Met Operating cash flow exceeds net income	CFO ₹4,196,550,000 vs Net Profit ₹2,783,230,000 (2026-03-31)	CashFlowsFromUsedInOperatingActivities vs ProfitOrLossAttributableToOwnersOfParent (2026-03-31)
✗ Not met Leverage (Debt/Assets) decreased YoY	2025-03-31 → 2026-03-31: 0.00% → 0.00%	Total Debt ÷ Total Assets, 2025-03-31 & 2026-03-31
✗ Not met Current ratio improved YoY	2025-03-31 → 2026-03-31: 5.53 → 3.59	Total Current Assets ÷ Total Current Liabilities, 2025-03-31 & 2026-03-31
✗ Not met No new shares issued	Equity Share Capital 2025-03-31 → 2026-03-31: ₹1,015,520,000 → ₹1,015,590,000	EquityShareCapital, 2025-03-31 & 2026-03-31
✗ Not met Operating margin (EBIT/Revenue) improved YoY	2025-03-31 → 2026-03-31: 26.55% → 25.68%	(ProfitBeforeExceptionalItemsAndTax + FinanceCosts) ÷ Revenue from Operations, 2025-03-31 & 2026-03-31
✗ Not met Asset turnover improved YoY	2025-03-31 → 2026-03-31: 0.64 → 0.61	Revenue from Operations ÷ Total Assets, 2025-03-31 & 2026-03-31